Qvents
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forums
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post a Job
Jobs posted by me
Users & Profiles
News
Login/Register
Individual
Company
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forums
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post a Job
Jobs posted by me
Users & Profiles
News
Login/Register
Method Validations
Qvents
1 minute read
Guidelines
Home
Guidelines
Method Validations
Updated on September 20, 2024
Home
Guidelines
Method Validations
Updated on September 20, 2024
ICH Q2(R2)
:
Validation of Analytical Procedures; Final Version; Adopted on 1 November 2023
ICH Q(14)
: A
nalytical Procedure Development; Final Version; Adopted on 1 November 2023
ICH Q2(R2)/Q14 EWG Working group presentation
; Analytical Procedure Development and Revision of Q2(R1) Analytical Validation
VICH
:
Validation of Analytical Procedures: Definition and Terminology [
CVM GFI #63 (VICH GL1)]
VICH:
Validation of Analytical Procedures: Methodology [CVM GFI #64 (VICH GL2)]
USFDA
Analytical Procedures and Methods Validation for Drugs and Biologics Guidance for Industry
USP 1225
: VALIDATION OF COMPENDIAL PROCEDURES (Please access USP to read)
Validation of Analytical Methods (IPC/GD/04)
–
Indian Pharmacopeia convention
EDQM
:
Comparability of alternative analytical procedures (5.27)
(Refer Ph Eur)
Tags :
Analytical Validation
,
Guidelines
,
ICH
,
Method Validation
Share:
Facebook
LinkedIn
Twitter
Search Posts
Latest Posts
USFDA 483 Cites Piramal Pharma for Investigation Deficiencies, Procedural Non-Compliance
March 13, 2025
Contamination Control and Data Integrity Issues: Granules India Receives USFDA Warning Letter
March 7, 2025
Janssen’s Korea Vaccine Unit USFDA 483 Cites Aseptic Operations Not in Control
February 26, 2025
Facility Registration Violations, Refusal of Inspection: Jagsonpal Issued Warning letter
February 22, 2025
Purified Water System Qualification and Control: USFDA Expectations
February 11, 2025